Dan Shores

Dan Shores is a dedicated attorney and strategist who believes in his clients and the power of their ideas. Dan applies a constructive, problem-solving approach to matters and excels at deciphering key translational aspects of a broad array of technologies to maximize leverage in the context of a client’s desired implementation of such technologies whether as participants in dynamic markets or as first movers.

Follow:

Ryder Launches $50M Venture Fund for Supply Chain Startups

By Dan Shores on October 30, 2020

Posted in Featured, Trends & Analysis

This week, Ryder System, Inc. (NYSE: R), announced a new corporate venture capital fund called RyderVentures.

The fund seeks to…
Continue Reading Ryder Launches $50M Venture Fund for Supply Chain Startups

Key Considerations Regarding Early Disclosures and Patent Protection

By Dan Shores & Anjali Jenna (AJ) Teigen on October 18, 2020

Posted in Guidance

Founders routinely need to disclose their groundbreaking technologies to third party investors, suitors, collaborators, peers, consultants and others in order…
Continue Reading Key Considerations Regarding Early Disclosures and Patent Protection

Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+

By Dan Shores on October 17, 2020

Posted in Trends & Analysis

Pharmaceutical giant Eli Lilly and Company will purchase four-year-old Disarm Therapeutics, a Cambridge-based biotechnology company, for $135 million up…
Continue Reading Eli Lilly to Buy Disarm Therapeutics for $135M Plus Potentially $1B+

University of Cambridge Develops Virtual Reality Software to Help Explore Cells

By Dan Shores on October 13, 2020

Posted in Trends & Analysis

Researchers at the University of Cambridge have developed software that produces super-resolution virtual, 3D images of cells contained in actual…
Continue Reading University of Cambridge Develops Virtual Reality Software to Help Explore Cells

Moderna Reportedly Won’t Enforce its COVID-19 Vaccine Patents

By Dan Shores on October 9, 2020

Posted in Trends & Analysis

Boston-based Moderna has announced that it will not enforce its patent rights related to its experimental vaccine for COVID-19, because…
Continue Reading Moderna Reportedly Won’t Enforce its COVID-19 Vaccine Patents

Aledia, French microLED Startup, Announces €80M First Tranche Close on €120M Round

By Dan Shores on October 7, 2020

Posted in Trends & Analysis

French microLED display startup Aledia announced it closed an €80M first tranche of its €120M D-round financing. The company will…
Continue Reading Aledia, French microLED Startup, Announces €80M First Tranche Close on €120M Round

Critical Steps for Building Winning Patent Portfolios

By Dan Shores on October 6, 2020

Posted in Featured, Guidance

Leaders of emerging companies must make many critical decisions at the outset of their company’s growth cycle, not the least…
Continue Reading Critical Steps for Building Winning Patent Portfolios